MENU
APR 29, 2021
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

OncomineWorld 2021: A virtual NGS education meeting


In 2020, we brought thousands of professionals together for our inaugural, virtual next-generation sequencing (NGS) education meetings. This year, we are back with new live presentations on April 29th!

Join us to hear from pathology labs on important topics like hot and emerging biomarker testing, such as genomic instability, and new user experiences with the Ion Torrent Genexus NGS System in solid and hematologic tumor clinical research.

What can you expect from OncomineWorld 2021?

In addition to our great lineup of live presentations, you will also have access to all that the OncomineWorld universe has to offer -

  •  Dozens of on-demand educational presentations from our 2020 meetings
  • Demonstrations of the Ion Torrent Genexus System, recorded from a Thermo Fisher Scientific lab
  • The latest NGS research from Thermo Fisher Scientific with new posters in the Poster Hall
  • New content in the Precision Oncology Hall, with all about why and how genomic profiling for precision oncology should be done in-house, locally and close to patients

Earn CE credits from on-demand or live presentations and explore our virtual laboratories to learn about the new world of easy and fast NGS – the Genexus System. Explore NGS application areas like emerging NSCLC biomarkers, comprehensive genomic profiling (CGP), liquid biopsy research, and hemato-oncology research.

 

Sincerely,

Your Thermo Fisher Scientific Oncology NGS team

 

For Research Use Only. Not for use in diagnostic procedures.


Speakers
  • Unipath Specialty Laboratory
  • Assistant Professor, Molecular Genetic Pathology and Neuropathology, Co-Director, Molecular Diagnostics Laboratory, University of Texas Health​ Science Center at Houston
  • Professor, University of Auckland
  • President, Clinical Next Generation Sequencing, Thermo Fisher Scientific
  • Associate Director, Product Management, Clinical Sequencing Division, Thermo Fisher Scientific
  • Professor of Molecular Pathology, University of Munich
  • Head of Department of Molecular Diagnostics, Holycross Cancer Center
  • Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
  • Associate Professor, Singapore General Hospital
  • Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
  • Product Manager, Clinical Sequencing Division, Thermo Fisher Scientific
  • Physician Lead of Research, Medical Director of Immunohistochemistry and Molecular Pathology, Department of Pathology, William Osler Health System
  • Senior Clinical Scientist, Department of Haematology, Royal Liverpool University Hospital

Show Resources
You May Also Like
APR 20, 2021 5:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
APR 20, 2021 5:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021! Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar exper...
APR 19, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 19, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 10th Annual Genetics Virtual Week held on April 19-21, 2022! Genetics Virtual Week 2022 will offer a multi-day content-rich program combining stellar expe...
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
Speakers

  • Neeraj Arora, MD, PDF
    Unipath Specialty Laboratory
    Biography

      I joined Tata Medical centre, Kolkata in 2013 and work in the service diagnostic laboratory as a consultant pathologist, taking care of the rotuine haematopathology, lymphoma pathology,  flow cytometry and Molecular genetics.  I along with my team have been involved in developing and implementing flowcytometry based minimal residual disease assays for haematological diseases like ALL and multiple myeloma. I have stong interest in lymphoma pathology and report the lymph nodes/bone marrow aspirates/biopsies.

      Under the guidance and vision of Dr Mammen Chandy (Director TMC) I have had the opportunity of successfully setting up affordable diagnostic molecular solutions for haematological and solid tumours using the latest techniques like NGS, digital PCR. Over the last 4-5 years we have successfully established and implemented molecular driven (Ion torrent based tissue genotyping for EGFR; digital PCR based T790M assays, cfDNA based EGFR genotyping, Oncomine comprehensve myeloid assays), standard treatment of care for our patients.

      I am involved in running and teaching fellows from the fellowship courses in haematopathology and molecular pathology.

    • Leomar Ballester, MD, PhD
      Assistant Professor, Molecular Genetic Pathology and Neuropathology, Co-Director, Molecular Diagnostics Laboratory, University of Texas Health​ Science Center at Houston
      Biography

        Dr. Ballester completed a B.S. in Biological Sciences at the University of Puerto Rico-Mayaguez, an M.D. degree at the UPR School of Medicine and a Ph.D. in pharmacology and genetics in the Department of Pharmacology at Vanderbilt University. Dr. Ballester joined the National Cancer Institute for Residency training in Anatomic Pathology (where he also served as chief resident). This was followed by fellowships in Molecular Genetic Pathology at Baylor College of Medicine and Neuropathology at the Houston Methodist/MDAnderson program. He is board certified by the American Board of Pathology in Anatomic Pathology, Neuropathology, and Molecular Genetic Pathology. Currently (since July 2017), Dr. Ballester has been an Assistant Professor in the Department of Pathology and Laboratory Medicine and the Department of Neurosurgery at the University of Texas Health Science Center in Houston. In addition to practicing clinical neuropathology, he serves as co-director of the Molecular Diagnostics Laboratory. He is also the principal investigator of an NIH-funded research program focusing on brain tumor biomarkers and minimally invasive diagnostic assays.

      • Cristin Gregor Print, PhD
        Professor, University of Auckland
        Biography

          Cris graduated in Medicine and Surgery from the University of Auckland in 1989 and began research while working as a house surgeon in Dunedin, NZ. A PhD in the University of Auckland led to a four-year postdoctoral fellowship in the Walter and Eliza Hall Institute in Melbourne, Australia before six years in Cambridge University, UK, where he was a Fellow of St Edmunds College and developed a deep interest in genomics and bioinformatics. While there he co-founded a bioinformatics company that became listed on the Tokyo stock exchange in 2007. In 2005 he returned to the University of Auckland where he leads a cross-disciplinary research team of clinicians, cell biologists and data scientists who use genomics, systems biology and bioinformatics to better understand human disease, especially cancer. He leads the Genomics Into Medicine Strategic Research Initiative in Auckland and Chairs the Auckland Regional Tissue Bank Scientific Advisory Board. He is a Deputy Chair of the NZ Institute of Environmental Science and Research (ESR) and a Principle Investigator in the Maurice Wilkins Centre. Previously, he served as President of the NZ Society for Oncology and was Director of the Bioinformatics Institute at the University of Auckland.

        • Garret Hampton
          President, Clinical Next Generation Sequencing, Thermo Fisher Scientific
        • Andrew Hutchison
          Associate Director, Product Management, Clinical Sequencing Division, Thermo Fisher Scientific
        • Dr. Andreas Jung
          Professor of Molecular Pathology, University of Munich
        • Artur Kowalik, Ph.D.
          Head of Department of Molecular Diagnostics, Holycross Cancer Center
          Biography

            Artur Kowalik, PhD, is a specialist in medical laboratory genetics. He is Head of the Department of Molecular Diagnostics at the Holycross Cancer Centre in Kielce. He also works at the Department of Medical Biology, Institute of Biology, Jan Kochanowski University in Kielce. The Department of Molecular Diagnostics performs molecular diagnostic tests for the patients treated in the Holycross Cancer Center in Kielce and many other centers in Poland. The group of tests performed includes stratification of patients with solid tumors for treatment with targeted therapies, detection of hereditary predisposition to cancer and diagnostics and monitoring of treatment effectiveness in hemato-oncology. The Department was the first in Poland to perform BRCA1/2 gene analysis for genetic counseling, using the NGS method. His research interests include cancer biology using modern molecular biology methods such as NGS and the application of liquid biopsy for cancer classification and monitoring of cancer treatment effectiveness.

          • Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
            Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
            Biography

              Dr. Xia Li is the Scientific Medical Director of Genetics/Genomics Division at Sonora Quest Laboratories and Associate Professor of Pathology Department at University of Arizona. She oversees the operation of the laboratory and participates in the teaching and training of medical students and residents. Dr. Li has been working in the field of Genetics/Genomics diagnostics since 2008, and was certified in both Molecular and Cytogenetics through ABMGG. Before joining Sonora Quest Laboratories in 2016, Dr. Li was the Associate Director of Cytogenetics Laboratory at Cincinnati Children’s Hospital from 2013 to 2016, and Associate Director of Cytogenetics Laboratory at AmeriPath Northeast from 2010 to 2013. She has extensive experience in cancer diagnostics using karyotyping, FISH, PCR, microarray and NGS technologies. She has published over 50 peer-reviewed articles and owns 2 patents. In her spare time, Dr. Li enjoys dancing, cooking, sewing, and hiking.

            • Dr. Tony Lim
              Associate Professor, Singapore General Hospital
              Biography

                Dr Tony Lim graduated with MBBS from National University of Singapore in 1998. He later then joined the Department of Pathology in Singapore General Hospital and finished his training in 2006, obtaining both FRCPath and FRCPA fellowships. After his HMDP in Liver and Gastrointestinal pathology at Mt Sinai Hospital in New York in 2008, he has returned to practice General Surgical pathology with special interest in Liver and Gastrointestinal Pathology, biliary tract diseases like pancreatobilary cancers and lung cancer. In the years of clinical research setting, he has been involved in numerous clinical trials with pharmaceutical companies and has authored and co-authored numerous publications. Currently, he is the Clinical Director of Personalized OMIC Lattice for Advanced Research and Improving Stratification (POLARIS)@Sing Health, a Sing Health Research Core Platform which utilizes Next Generation Sequencing (NGS) technology to conduct tests and aims to translate novel scientific discoveries into clinically validated assays.

              • Nicola Normanno, MD
                Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
                Biography

                  Dr. Normanno, MD earned his Medical Doctor Degree in 1988 at the Medical School, University of Naples (Italy) Federico II. After a residency in Oncology at the Oncology Department of the same university, in 1991 he achieved the specialisation in Medical Oncology, and in 2001 in Haematology. Between 1990 and 1993, Dr Normanno did a postdoctoral fellowship at the Tumor Growth Factor Section, Laboratory of Tumour Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. After being senior Investigator and later Acting Chief (2004-2005) at the Experimental Therapy Section, INT-Fondazione Pascale, Naples, Dr Normanno is currently Director of the Cell Biology and Biotherapy-Unit at the same Hospital, and since 2006 also Director of the Translational Research Department. Since 1993 Dr Normanno's area of research has been the study of the role of growth factors and receptors of the EGF family in the pathogenesis of solid tumors; the identification of markers of response or resistance to anti-EGFR agents; the implementation of precision medicine in the path of care of cancer patients. Dr Normanno is a member of the European Society for Medical Oncology (ESMO), the American Association for Cancer Research (AACR), the Italian Association of Medical Oncology (AIOM), and the Italian Cancer Society (SIC). He is from 2018 President of the International Quality Network for Pathology (IQN Path) and from 2020 President of the Italian Cancer Society (SIC). Dr Normanno is a reviewer for several peer-reviewed journals including Annals of Oncology, Clinical Cancer Research, International Journal of Cancer, European Journal of Cancer, British Journal of Cancer, Nature Communications. He is also Editor of Exploration of Targeted Anti-tumor Therapy and Associate Editor of BMC Cancer and Gene. Dr Normanno is the author of over 200 papers published in peer-reviewed journals with an H Index of 68.

                • Uma Ramasubramanian
                  Product Manager, Clinical Sequencing Division, Thermo Fisher Scientific
                • Brandon Sheffield, MD, FRCPC
                  Physician Lead of Research, Medical Director of Immunohistochemistry and Molecular Pathology, Department of Pathology, William Osler Health System
                  Biography

                    Dr. Brandon Sheffield is an anatomic and molecular pathologist with the William Osler Health System. He is currently serving as the Medical Director of Immunohistochemistry and Molecular Pathology, and the Physician Lead of research for William Osler Health System.

                    Dr. Sheffield’s principal focus is on the delivery of personalized medicine and precision oncology, with a specific attention to making molecular testing available to community cancer patients in Canada.

                  • Lihui Wang, Ph.D.
                    Senior Clinical Scientist, Department of Haematology, Royal Liverpool University Hospital
                    Biography

                      Dr. Lihui Wang obtained her quantification in Medicine in Peking University, China and her PhD degree in the University of Liverpool. She has been active in research on a variety of haematological malignancies in China, France, Scotland and England. Dr. Wang has been a Senior Clinical Scientist in Department of Haematology, Royal Liverpool University Hospital since year 2000. She has integrated both research project and NHS service to improve the molecular diagnosis, prognosis and monitoring for patients with haematological malignancies. Her research was mainly in investigating the role of BCR-ABL1 gene transcript monitoring in CML (Chronic Myeloid Leukaemia) patients under various clinical settings, the mechanism of tyrosine kinase inhibitor resistance in CML and the molecular mechanism of CML blast crisis (BC) transformation.

                      Dr. Wang has been involved in establishing and standardising BCR-ABL1 gene transcript monitoring in Liverpool, UK and across the world (WHO standard). Her role in NHS service was to establish and supervise molecular diagnostic and molecular monitoring service for patients with chronic myeloid leukaemia (CML), acute leukaemia and myeloproliferative neoplasms (MPN). Since 2018, Dr. Wang has been the Lead Scientist for Molecular Diagnostics, Haemato-oncology Diagnostic Service (HODS) in Royal Liverpool University Hospital. Her role was to establish and supervise the Haemato-oncology molecular diagnostic service for the region of Merseyside and Cheshire. Since 2019, Dr. Wang has been the Lead Scientist for NHS England Northwest Liverpool LCL Genomic Laboratory Hub (GLH).

                    Agenda
                    • A clinical-research-industry collaboration to bring blood genomics to cancer patients in New Zealand
                      APR 29, 2021 12:05 PM +08
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      A clinical-research-industry collaboration to bring blood genomics to cancer patients in New Zealand
                      Cristin Gregor Print, PhD
                      Professor, University of Auckland
                    • Point of care NGS in community practice
                      APR 29, 2021 12:05 PM PDT
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Point of care NGS in community practice
                      Brandon Sheffield, MD, FRCPC
                      Physician Lead of Research, Medical Director of Immunohistochemistry and Molecular Pathology, Department of Pathology, William Osler Health System
                    • Current and upcoming pharma collaboration and IVD strategy
                      APR 29, 2021 12:25 PM PDT
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Current and upcoming pharma collaboration and IVD strategy
                      Garret Hampton
                      President, Clinical Next Generation Sequencing, Thermo Fisher Scientific
                      Continuing Education: Florida CE | P.A.C.E. CE
                    • Comprehensive Genomic Profiling, an Asia Pacific Perspective - AsPION Project
                      APR 29, 2021 12:55 PM +08
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Comprehensive Genomic Profiling, an Asia Pacific Perspective - AsPION Project
                      Dr. Tony Lim
                      Associate Professor, Singapore General Hospital
                    • Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
                      APR 29, 2021 1:15 PM PDT
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
                      Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
                      Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
                    • Validation of combined DNA and RNA sequencing in Myeloid neoplasms
                      APR 29, 2021 1:15 PM +08
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Validation of combined DNA and RNA sequencing in Myeloid neoplasms
                      Neeraj Arora, MD, PDF
                      Unipath Specialty Laboratory
                      Continuing Education: Florida CE | P.A.C.E. CE
                    • Experience with the Oncomine Precision Assay on Genexus System
                      APR 29, 2021 1:35 PM PDT
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Experience with the Oncomine Precision Assay on Genexus System
                      Leomar Ballester, MD, PhD
                      Assistant Professor, Molecular Genetic Pathology and Neuropathology, Co-Director, Molecular Diagnostics Laboratory, University of Texas Health​ Science Center at Houston
                      Continuing Education: Florida CE | P.A.C.E. CE
                    • TBD
                      APR 29, 2021 1:35 PM +08
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      TBD
                      Speaker First & Last Name, Credentials
                      Job Title, Institution/Company
                    • APR 29, 2021 2:10 PM +08
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Genexus System and Genexus Software Demo
                      Andrew Hutchison, Uma Ramasubramanian
                      Andrew Hutchison
                      Associate Director, Product Management, Clinical Sequen...
                      Uma Ramasubramanian
                      Product Manager, Clinical Sequencing Division, Thermo F...
                    • APR 29, 2021 2:10 PM PDT
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Genexus System and Genexus Software Demo
                      Andrew Hutchison, Uma Ramasubramanian
                      Andrew Hutchison
                      Associate Director, Product Management, Clinical Sequen...
                      Uma Ramasubramanian
                      Product Manager, Clinical Sequencing Division, Thermo F...
                    • The value of the Genexus System in pathology extended for use in SARS-CoV-2 sequencing
                      APR 29, 2021 3:05 PM CEST
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      The value of the Genexus System in pathology extended for use in SARS-CoV-2 sequencing
                      Nicola Normanno, MD
                      Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
                      Continuing Education: Florida CE | P.A.C.E. CE
                    • NSCLC molecular profiling: An NGS based approach using Oncomine Solutions
                      APR 29, 2021 3:25 PM CEST
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      NSCLC molecular profiling: An NGS based approach using Oncomine Solutions
                      Artur Kowalik, Ph.D.
                      Head of Department of Molecular Diagnostics, Holycross Cancer Center
                    • Comprehensive Genomic Profiling for Homologous Recombination Repair Deficiency (HRD) Assessment
                      APR 29, 2021 4:00 PM CEST
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Comprehensive Genomic Profiling for Homologous Recombination Repair Deficiency (HRD) Assessment
                      Dr. Andreas Jung
                      Professor of Molecular Pathology, University of Munich
                    • Haematological malignancy samples molecular characterization - in a NGS way
                      APR 29, 2021 4:20 PM CEST
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Haematological malignancy samples molecular characterization - in a NGS way
                      Lihui Wang, Ph.D.
                      Senior Clinical Scientist, Department of Haematology, Royal Liverpool University Hospital
                    • APR 29, 2021 4:55 PM CEST
                      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                      Genexus System and Genexus Software Demo
                      Andrew Hutchison, Uma Ramasubramanian
                      Andrew Hutchison
                      Associate Director, Product Management, Clinical Sequen...
                      Uma Ramasubramanian
                      Product Manager, Clinical Sequencing Division, Thermo F...
                    • Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
                      OCT 22, 2020 1:35 PM PDT
                      Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
                      Jane Bayani, PhD
                      Principal Research Scientist, Ontario Institute for Cancer Research
                    • Utilizing the Genexus System to Detect Complex Genetic Variants in Human Tissue Specimens
                      OCT 22, 2020 1:15 PM PDT
                      Utilizing the Genexus System to Detect Complex Genetic Variants in Human Tissue Specimens
                      Craig Mackinnon, MD, PhD
                      Director, Genomic Diagnostics and Bioinformatics - Professor, Department of Pathology, University of Alabama at Birmingham
                    • Clinical impact of Next-Generation Sequencing (NGS) Testing: A hematopathologist's perspective
                      OCT 22, 2020 12:25 PM PDT
                      Clinical impact of Next-Generation Sequencing (NGS) Testing: A hematopathologist's perspective
                      Megan S. Lim, MD, PhD
                      Director of the Division of Hematopathology, Hospital of the University of Pennsylvania
                    • Molecular Testing of NSCLC Biopsies: Making mountains out of molehills
                      OCT 22, 2020 12:05 PM PDT
                      Molecular Testing of NSCLC Biopsies: Making mountains out of molehills
                      Carmen Kletecka, MD, FCAP, FASCP
                      Medical Director, Molecular Oncology Diagnostics Laboratory - U.S. Department of Veterans Affairs
                    • First Experiences with Oncomine™ Comprehensive Assay Plus for comprehensive genomic profiling
                      OCT 22, 2020 4:40 PM CEST
                      First Experiences with Oncomine™ Comprehensive Assay Plus for comprehensive genomic profiling
                      Ines Raineri, MD
                      Staff Pathologist, Institute for Pathology medica AG
                    • NGS evolution in Solid Tumours, from S5-XL to Genexus
                      OCT 22, 2020 4:20 PM CEST
                      NGS evolution in Solid Tumours, from S5-XL to Genexus
                      Javier Hernandez-Losa, PhD
                      Director of Molecular Biology Laboratory, Department of Pathology - Vall d´Hebron Hospital
                    • Next Generation rEvolution in Myeloid Neoplasms clinical research
                      OCT 22, 2020 3:35 PM CEST
                      Next Generation rEvolution in Myeloid Neoplasms clinical research
                      Giada Rotunno, PhD
                      Research Scientist, University of Florence
                    • NGS for precision oncology in solid tumors: from research to clinical practice
                      OCT 22, 2020 3:05 PM CEST
                      NGS for precision oncology in solid tumors: from research to clinical practice
                      Nicola Normanno, MD
                      Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
                    • Latest Developments with the Genexus System
                      OCT 22, 2020 1:35 PM SGT
                      Latest Developments with the Genexus System
                      Dr. Jose Luis Costa
                      Medical Director, Thermo Fisher Scientific
                    • OCA Plus DNA evaluation for comprehensive genomic profiling in clinical research
                      OCT 22, 2020 1:15 PM SGT
                      OCA Plus DNA evaluation for comprehensive genomic profiling in clinical research
                      Ahwon Lee, MD, PhD
                      Professor, Catholic University of Korea and Pathologist, Seoul St. Mary's Hospital
                    • The role of PARPis and HRD testing in advanced ovarian cancer
                      OCT 22, 2020 12:25 PM SGT
                      The role of PARPis and HRD testing in advanced ovarian cancer
                      Natalie Ngoi, MBBS, MMed, MRCP
                      Associate Consultant, National University Cancer Institute, Singapore
                    • Incorporating NGS in an Asian non-small cell lung cancer (NSCLC) population - a cost-effectiveness analysis
                      OCT 22, 2020 12:05 PM SGT
                      Incorporating NGS in an Asian non-small cell lung cancer (NSCLC) population - a cost-effectiveness analysis
                      Aaron Tan, PhD
                      Oncology Fellow, Resident Physician, National Cancer Centre, Singapore
                    • Haemato-Oncology Applications of BCR Immune Repertoire Sequencing
                      MAY 14, 2020 7:05 PM EDT
                      Haemato-Oncology Applications of BCR Immune Repertoire Sequencing
                      Timothy Looney, PhD
                      Associate Director, Bioinformatics; Clinical Next-Generation Sequencing
                    • Genomic profiling of prostate cancer cells from urine using Oncomine Pan Cancer Cell Free Assay
                      MAY 14, 2020 6:40 PM EDT
                      Genomic profiling of prostate cancer cells from urine using Oncomine Pan Cancer Cell Free Assay
                      Jane Bayani, PhD
                      Principal Research Scientist, Ontario Institute for Cancer Research
                    • Experience with Oncomine Myeloid Research Assay
                      MAY 14, 2020 6:05 PM EDT
                      Experience with Oncomine Myeloid Research Assay
                      Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
                      Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
                    • First experience with the Ion Torrent Genexus Workflow
                      MAY 14, 2020 5:40 PM EDT
                      First experience with the Ion Torrent Genexus Workflow
                      Kojo Elenitoba-Johnson, MD
                      Director, Center for Personalized Diagnostics Director, Division of Precision and Computational Diagnostics, University of Pennsylvania Perelman School of Medicine
                    • Molecular Profiling for Treatment Guidance of Hematologic Malignancies by Next Generation Sequencing
                      MAY 14, 2020 5:00 PM EDT
                      Molecular Profiling for Treatment Guidance of Hematologic Malignancies by Next Generation Sequencing
                      Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
                      Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
                    • Lymphoid and Myeloid NGS Molecular Characterization - Assessing the Journey to Answers
                      MAY 14, 2020 4:40 PM CEST
                      Lymphoid and Myeloid NGS Molecular Characterization - Assessing the Journey to Answers
                      Marianne Grantham
                      Clinical Scientist, Head of Cytogenetics and Molecular Haematology, Barts Health NHS Trust The Royal London Hospital
                    • Advantages and Challenges of Broad Molecular Profiling
                      MAY 14, 2020 4:15 PM CEST
                      Advantages and Challenges of Broad Molecular Profiling
                      Ilaria Alborelli, PhD
                      Scientific Operations Manager, Molecular Assay Development Unit Institute of Medical Genetics and Pathology, University Hospital of Basel - Switzerland
                    • Genexus - A Major Step Forward in Diagnostic NGS
                      MAY 14, 2020 3:30 PM CEST
                      Genexus - A Major Step Forward in Diagnostic NGS
                      Michael Hummel, PhD
                      Head of Molecular Pathology, Charité - Universitätsmedizin Berlin, Institute of Pathology, Germany
                    • Analysis of Solid Tumor Genomic Landscape in Liquid Biopsy
                      MAY 14, 2020 3:00 PM CEST
                      Analysis of Solid Tumor Genomic Landscape in Liquid Biopsy
                      Nicola Normanno, MD
                      Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
                    • Emerging Biomarkers in Non-small Cell Lung Cancer
                      MAY 14, 2020 3:00 PM CEST
                      Emerging Biomarkers in Non-small Cell Lung Cancer
                      Luca Quagliata, PhD
                      Global Head of Medical Affairs, Clinical NGS and Oncology Division, Thermo Fisher Scientific
                    • Oncomine Precision Assay on Ion Torrent Genexus System for liquid biopsy sample
                      MAY 14, 2020 2:40 PM SGT
                      Oncomine Precision Assay on Ion Torrent Genexus System for liquid biopsy sample
                      Siew-Kee (Amanda) Low, PhD
                      Group Leader for Cancer Neoantigen Vaccine Development Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research (JFCR)
                    • First Experience from New World of Easy NGS - Ion Torrent Genexus Workflow
                      MAY 14, 2020 2:15 PM SGT
                      First Experience from New World of Easy NGS - Ion Torrent Genexus Workflow
                      Philip Jermann, PhD
                      Director of the Molecular Assay Development Unit, Institute of Pathology and Medical Genetics of Basel
                    • NATA Accreditation of Next Generation Sequencing for CDx Testing
                      MAY 14, 2020 1:25 PM SGT
                      NATA Accreditation of Next Generation Sequencing for CDx Testing
                      Luke Hesson, PhD, FFScRCPA
                      Laboratory Director, KCCG Sequencing Facility & Cancer Diagnostics​, Australia
                    • Test Validation in Medical Laboratories: the Australian Perspective
                      MAY 14, 2020 1:25 PM SGT
                      Test Validation in Medical Laboratories: the Australian Perspective
                      Luke Hesson, PhD, FFScRCPA
                      Laboratory Director, KCCG Sequencing Facility & Cancer Diagnostics​, Australia
                    • Implementation of Multigene Testing for 1st line NSCLC - A Malaysian initiative
                      MAY 14, 2020 1:00 PM SGT
                      Implementation of Multigene Testing for 1st line NSCLC - A Malaysian initiative
                      Dr. Pathmanathan Rajadurai, MBBS, FRCPA, FRCPath
                      Senior Consultant Pathologist and Laboratory Director
                    • Asia Pacific Session 1
                      • Part 1: General education in precision oncology
                      • A clinical-research-industry collaboration to bring blood genomics to cancer patients in New Zealand
                        APR 29, 2021 12:05 PM +08
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        A clinical-research-industry collaboration to bring blood genomics to cancer patients in New Zealand
                        Cristin Gregor Print, PhD
                        Professor, University of Auckland
                      • Part 2: Experiences with Oncomine Solutions for clinical research Part 2
                      • Comprehensive Genomic Profiling, an Asia Pacific Perspective - AsPION Project
                        APR 29, 2021 12:55 PM +08
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        Comprehensive Genomic Profiling, an Asia Pacific Perspective - AsPION Project
                        Dr. Tony Lim
                        Associate Professor, Singapore General Hospital
                      • Validation of combined DNA and RNA sequencing in Myeloid neoplasms
                        APR 29, 2021 1:15 PM +08
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        Validation of combined DNA and RNA sequencing in Myeloid neoplasms
                        Neeraj Arora, MD, PDF
                        Unipath Specialty Laboratory
                        Continuing Education: Florida CE | P.A.C.E. CE
                      • TBD
                        APR 29, 2021 1:35 PM +08
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        TBD
                        Speaker First & Last Name, Credentials
                        Job Title, Institution/Company
                    • Europe/North America Live Session 2
                      • PART 1 EXPERIENCES WITH ONCOMINE SOLUTIONS FOR CLINICAL RESEARCH PART 1
                      • The value of the Genexus System in pathology extended for use in SARS-CoV-2 sequencing
                        APR 29, 2021 3:05 PM CEST
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        The value of the Genexus System in pathology extended for use in SARS-CoV-2 sequencing
                        Nicola Normanno, MD
                        Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
                        Continuing Education: Florida CE | P.A.C.E. CE
                      • NSCLC molecular profiling: An NGS based approach using Oncomine Solutions
                        APR 29, 2021 3:25 PM CEST
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        NSCLC molecular profiling: An NGS based approach using Oncomine Solutions
                        Artur Kowalik, Ph.D.
                        Head of Department of Molecular Diagnostics, Holycross Cancer Center
                      • Part 2: Experiences with Oncomine Solutions for clinical research Part 2
                      • Comprehensive Genomic Profiling for Homologous Recombination Repair Deficiency (HRD) Assessment
                        APR 29, 2021 4:00 PM CEST
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        Comprehensive Genomic Profiling for Homologous Recombination Repair Deficiency (HRD) Assessment
                        Dr. Andreas Jung
                        Professor of Molecular Pathology, University of Munich
                      • Haematological malignancy samples molecular characterization - in a NGS way
                        APR 29, 2021 4:20 PM CEST
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        Haematological malignancy samples molecular characterization - in a NGS way
                        Lihui Wang, Ph.D.
                        Senior Clinical Scientist, Department of Haematology, Royal Liverpool University Hospital
                    • America's Live Session 3
                      • Part 1: General education in precision oncology
                      • Point of care NGS in community practice
                        APR 29, 2021 12:05 PM PDT
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        Point of care NGS in community practice
                        Brandon Sheffield, MD, FRCPC
                        Physician Lead of Research, Medical Director of Immunohistochemistry and Molecular Pathology, Department of Pathology, William Osler Health System
                      • Part 3: Experiences with Oncomine solutions for clinical research
                      • Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
                        APR 29, 2021 1:15 PM PDT
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
                        Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
                        Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
                      • Experience with the Oncomine Precision Assay on Genexus System
                        APR 29, 2021 1:35 PM PDT
                        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                        Experience with the Oncomine Precision Assay on Genexus System
                        Leomar Ballester, MD, PhD
                        Assistant Professor, Molecular Genetic Pathology and Neuropathology, Co-Director, Molecular Diagnostics Laboratory, University of Texas Health​ Science Center at Houston
                        Continuing Education: Florida CE | P.A.C.E. CE
                    C.E. Credits

                    The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                    Help

                    General Labroots Questions

                    email support@labroots.com  

                    Virtual Events and Webinars

                    Supported Configurations

                    • Operating System Internet Explorer Firefox Chrome Safari
                      Vista IE8+ FF10+ Chrome15+
                      Windows 7 IE8+ FF10+ Chrome15+
                      Windows 8 IE10 FF10+ Chrome15+
                      Mac OS X   FF10+ Chrome15+ Safari5.1+
                    • Cookie settings: session cookies enabled
                    • Browser configuration must have JavaScript enabled
                    • Adobe Flash player 10.2 or later

                    To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                    Internet Connection

                    • A minimum of 100Kbps is recommended for audio-only events
                    • A minimum of 300Kbps is recommended for speaker on-video events

                    Computer Equipment

                    • Screen Resolution: Minimum 1024x768
                    • Video Card: 65,000 colors minimum
                    • Sound card and speakers (or headphones) for hearing webcast in full format
                    • Audio Card: 16-bit minimum
                    • RAM: 512MB of free RAM

                    Firewall Protocol

                    • HTTP on port 80 or HTTPS on port 443
                    • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                    • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                    Work-At-Home Attendees

                    • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                    For A Seamless Experience

                    When using a mobile device, FREE Mobile Apps are available:

                    - For viewing Webinars:

                    - For viewing Virtual Events

                    Attendee Guide

                    • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                    Virtual Event and Webinar Support:

                    Continuing Education (CME/CE) Support

                    Demographics

                    Specialty

                    Cancer

                    Molecular Genetics

                    Molecular Diagnostics

                    Molecular Biology

                    Cancer Research

                    Research And Development

                    Genetics

                    Personalized Medicine

                    Gene

                    Research

                    Cancer Diagnostics

                    Genomics

                    Human Genetics

                    Oncology

                    Clinical Medicine

                    Geography

                    North America31%

                    Asia23%

                    Europe23%

                    South America5%

                    Africa3%

                    Oceania2%

                    Registration Source

                    Website Visitors82%

                    Labroots Registration (Also interested in)5%

                    Social Media Promotions1%

                    Job Title

                    Executive11%

                    Facility/Department Manager11%

                    Research Scientist10%

                    Student9%

                    Medical Doctor/Specialist8%

                    Educator/Faculty8%

                    Scientist7%

                    Lab Management6%

                    Marketing/Sales5%

                    Biologist5%

                    Medical Laboratory Technician5%

                    Clinical Laboratory Scientist4%

                    Pathologist4%

                    Post Doc3%

                    Consultant3%

                    Engineer1%

                    Organization

                    Academic Institution20%

                    Hospital13%

                    Biotech Company10%

                    Clinical Laboratory8%

                    Life Science Company5%

                    Research Institute4%

                    Diagnostic Company3%

                    Government3%

                    Distribution/sales2%

                    Pharmaceutical Company2%

                    Consultant2%

                    Medical Center1%

                    Government/public1%

                    Medical School1%

                    Other4%

                    Loading Comments...
                    Show Resources
                    Event Countdown
                    • 0 Days
                    • 0 Hours
                    • 0 Minutes
                    • 0 Seconds
                    Attendees
                    • See more